rawfin.tv
TCG Crossover Fund II Discloses 5% Stake in LB Pharmaceuticals
RegulationstocksAI Generated

TCG Crossover Fund II Discloses 5% Stake in LB Pharmaceuticals

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

TCG Crossover Fund II, L.P., along with TCG Crossover GP II, LLC and Chen Yu, has reported a 5.0% beneficial ownership stake in LB Pharmaceuticals. This disclosure was made via a 13G/A SEC filing.

LBRXSEC filingbeneficial ownershipinvestor group

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks